Martine Zimmermann - 22 Sep 2026 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Reporting relationship: Director
Issuer ticker: LGND
Reported as of: 22 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Sep 2026, 17:22:25 UTC
Prior SEC filing: 14 Sep 2026
Source filing: View source filing
Reporting owner signature: By: /s/Andrew Reardon, Attorney-in-Fact For: Martine Zimmerman

Key filing fact

Martine Zimmermann filed Form 4 for LIGAND PHARMACEUTICALS INC (LGND) on 24 Sep 2026.

Key facts

This page summarizes Martine Zimmermann's Form 4 filing for LIGAND PHARMACEUTICALS INC (LGND).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Sep 2026, 17:22.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001994049 Primary reporting owner

Shares, units, or other non-derivative securities reported in this filing.

LGND transaction

Tax liability

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.